Abstract

Every third colorectal cancer patient has inoperable metastatic disease upon diagnosis. And quite often the primary tumor is asymptomatic. The question stands for surgeon and medical oncologist, whether to proceed with upfront surgery or systemic chemotherapy. Considering the absence of prospective randomized clinical trials, we must discuss all potential benefits and drawbacks of both approaches, biological interactions between the primary tumor and metastases, risk of complications, associated with primary tumor during chemotherapy, relative efficacy of chemotherapy for primary tumor and metastatic nodes, we must perform a retrospective analysis of prognostic value of primary tumor resection. This review discusses all of the aforementioned questions.

Highlights

  • Every third colorectal cancer patient has inoperable metastatic disease upon diagnosis

  • Considering the absence of prospective randomized clinical trials, we must discuss all potential benefits and drawbacks of both approaches, biological interactions between the primary tumor and metastases, risk of complications, associated with primary tumor during chemotherapy, relative efficacy of chemotherapy for primary tumor and metastatic nodes, we must perform a retrospective analysis of prognostic value of primary tumor resection

  • Ishihara и соавт. в 2015 г. описали свой подход ент уже восстановился после проведенного хирурги- к оценке роли удаления первичной опухоли у больных ческого вмешательства, если же реабилитация больного с метастатическим раком толстой кишки (РТК)

Read more

Summary

Introduction

Every third colorectal cancer patient has inoperable metastatic disease upon diagnosis. Это исследование мы нако сравниваемые группы различались по таким считаем интересным, потому что авторы попытались значимым прогностическим факторам, как уровни определить факторы риска возникновения осложне- РЭА, щелочной фосфатазы и локализация опухоли ний со стороны первичной опухоли в процессе ХТ, в ободочной кишке.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.